128 Matching Annotations
  1. Last 7 days
  2. Mar 2026
  3. Feb 2026
  4. Jan 2026
  5. Dec 2025
  6. Nov 2025
  7. Oct 2025
  8. Sep 2025
  9. May 2025
  10. Mar 2025
  11. Feb 2025
  12. Dec 2024
  13. Oct 2024
  14. Sep 2024
  15. Aug 2024
  16. Jul 2024
  17. Apr 2024
  18. Mar 2024
  19. Jan 2024
  20. Dec 2023
  21. Oct 2023
  22. Sep 2023
  23. Aug 2023
  24. Jul 2023
  25. Mar 2023
  26. Feb 2023
  27. Jan 2023
  28. Nov 2022
  29. Oct 2022
  30. Aug 2022
  31. Jun 2022
  32. May 2022
  33. Apr 2022
  34. Mar 2022
  35. Feb 2022
  36. Jan 2022
  37. Dec 2021
  38. Nov 2021
  39. Oct 2021
  40. Sep 2021
  41. Aug 2021
  42. Jul 2021
  43. Jun 2021
  44. May 2021
  45. Apr 2021
  46. Mar 2021
  47. Feb 2021
  48. Nov 2020
  49. Oct 2020
  50. Sep 2020
  51. Jan 2020
  52. Nov 2018
  53. Nov 2017
    1. Before adding the fluorescently labeled antibodies, Fc-receptors were blocked with anti-CD16/CD32 (Pharmingen) antibodies was performed. Mammary epithelial cells were labeled with antibodies directed against CD24 (Pharmingen #553261), CD49f (Pharmingen #551129) and CD61 (eBioscience #11-0622-82). Non-epithelial cells were excluded using antibodies directed against CD45 (BD #553078), CD31 (BioLegend #102404) and Ter119 (BioLegend #116204)

      Curator: @bandrow

      Curator note: BioLegend Cat# 116204, RRID:AB_313705

      Resource used:

      (BioLegend Cat# 116204, RRID:AB_313705)

      SciCrunch record: RRID:AB_313705

      Alternate resolvers: SciCrunch xml N2T identifiers.org


      What is this?